FDA will consider Moderna's mRNA flu vaccine after all
Vaccine maker Moderna says the Food and Drug Administration will decide whether to approve its new flu shot for older adults after all.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
